Clinical Trial Update: Evaluation of [18F]-FMISO for Non Operated Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating [18F]-FMISO PET imaging for non-operated glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 18F-FMISO (fluoromisonidazole)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED